Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Simone Reu
Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma
Tumor Biology and Immunology Xiang Zheng, Andreas Weigert, Simone Reu, Stefan Guenther, Siavash Mansouri, Birgit Bassaly, Stefan Gattenlöhner, Friedrich Grimminger, Soni Savai Pullamsetti, Werner Seeger, Hauke Winter and Rajkumar Savai DOI: 10.1158/0008-5472.CAN-20-0069 Published October 2020 This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma
Tumor Biology and Immunology Xiang Zheng, Andreas Weigert, Simone Reu, Stefan Guenther, Siavash Mansouri, Birgit Bassaly, Stefan Gattenlöhner, Friedrich Grimminger, Soni Savai Pullamsetti, Werner Seeger, Hauke Winter and Rajkumar Savai DOI: 10.1158/0008-5472.CAN-20-0069 Abstract The respective antitumoral and protumoral roles of M1 and M2 tumor-associated macrophages (TAM) typify the complexity of macrophage function in cancer.
Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small-Cell Lung Carcinoma
Research Article Xiang Zheng, Andreas Weigert, Simone Reu, Stefan Guenther, Siavash Mansouri, Birgit Bassaly, Stefan Gattenlöhner, Friedrich Grimminger, Soni Savai Pullamsetti, Werner Seeger, Hauke Winter and Rajkumar Savai DOI: 10.1158/0008-5472.CAN-20-0069 Abstract The respective anti-tumoral and pro-tumoral roles of M1 and M2 tumor-associated macrophages (TAM) typify the complexity of macrophage function in cancer.
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
Rudolf M. Huber, Dirk De Ruysscher, Hans Hoffmann, Simone Reu, Amanda Tufman European Respiratory Review 2019 28: 190024; DOI: 10.1183/16000617.0024-2019 Abstract Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients and is very heterogeneous with varying and mostly poor prognosis. It is also called “locoregionally or locally advanced disease”. Due to its heterogeneity a general schematic management approach is not appropriate.
International management platform for children’s interstitial lung disease (chILD-EU)
In chILD, there is a pressing need for both specialised diagnostic advice from international experts because of the rareness of individual diagnoses and services to provide local care and therapy.
International management platform for children’s interstitial lung disease (chILD-EU)
Background Children’s interstitial lung diseases (chILD) cover many rare entities, frequently not diagnosed or studied in detail. There is a great need for specialised advice and for internationally agreed subclassification of entities collected in a register. Our objective was to implement an international management platform with independent multidisciplinary review of cases at presentation for long-term follow-up and to test if this would allow for more accurate diagnosis.
International management platform for children’s interstitial lung disease (chILD-EU)
Background Children’s interstitial lung diseases (chILD) cover many rare entities, frequently not diagnosed or studied in detail. There is a great need for specialised advice and for internationally agreed subclassification of entities collected in a register. Our objective was to implement an international management platform with independent multidisciplinary review of cases at presentation for long-term follow-up and to test if this would allow for more accurate diagnosis.
Lung disease caused by ABCA3 mutations
Results Of 22 homozygous (15 male) and 18 compound heterozygous patients (3 male), 37 presented with neonatal respiratory distress syndrome as term babies. At follow-up, two major phenotypes are documented: patients with (1) early lethal mutations subdivided into (1a) dying within the first 6?months or (1b) before the age of 5?years, and (2) patients with prolonged survival into childhood, adolescence or adulthood.
Lung disease caused by ABCA3 mutations
Results Of 22 homozygous (15 male) and 18 compound heterozygous patients (3 male), 37 presented with neonatal respiratory distress syndrome as term babies. At follow-up, two major phenotypes are documented: patients with (1) early lethal mutations subdivided into (1a) dying within the first 6?months or (1b) before the age of 5?years, and (2) patients with prolonged survival into childhood, adolescence or adulthood.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Simone
Contact Simone, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack